These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 28374168

  • 1. SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations.
    Jochmanova I, Wolf KI, King KS, Nambuba J, Wesley R, Martucci V, Raygada M, Adams KT, Prodanov T, Fojo AT, Lazurova I, Pacak K.
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1421-1435. PubMed ID: 28374168
    [Abstract] [Full Text] [Related]

  • 2. The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers.
    Rijken JA, Niemeijer ND, Jonker MA, Eijkelenkamp K, Jansen JC, van Berkel A, Timmers HJLM, Kunst HPM, Bisschop PHLT, Kerstens MN, Dreijerink KMA, van Dooren MF, van der Horst-Schrivers ANA, Hes FJ, Leemans CR, Corssmit EPM, Hensen EF.
    Clin Genet; 2018 Jan; 93(1):60-66. PubMed ID: 28503760
    [Abstract] [Full Text] [Related]

  • 3. The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study.
    Schovanek J, Martucci V, Wesley R, Fojo T, Del Rivero J, Huynh T, Adams K, Kebebew E, Frysak Z, Stratakis CA, Pacak K.
    BMC Cancer; 2014 Jul 21; 14():523. PubMed ID: 25048685
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD.
    Andrews KA, Ascher DB, Pires DEV, Barnes DR, Vialard L, Casey RT, Bradshaw N, Adlard J, Aylwin S, Brennan P, Brewer C, Cole T, Cook JA, Davidson R, Donaldson A, Fryer A, Greenhalgh L, Hodgson SV, Irving R, Lalloo F, McConachie M, McConnell VPM, Morrison PJ, Murday V, Park SM, Simpson HL, Snape K, Stewart S, Tomkins SE, Wallis Y, Izatt L, Goudie D, Lindsay RS, Perry CG, Woodward ER, Antoniou AC, Maher ER.
    J Med Genet; 2018 Jun 21; 55(6):384-394. PubMed ID: 29386252
    [Abstract] [Full Text] [Related]

  • 8. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
    Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C, European-American Paraganglioma Study Group.
    JAMA; 2004 Aug 25; 292(8):943-51. PubMed ID: 15328326
    [Abstract] [Full Text] [Related]

  • 9. Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletion.
    Rijken JA, Niemeijer ND, Corssmit EP, Jonker MA, Leemans CR, Menko FH, Hensen EF.
    Clin Genet; 2016 Jan 25; 89(1):128-32. PubMed ID: 25827221
    [Abstract] [Full Text] [Related]

  • 10. Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD.
    Ricketts CJ, Forman JR, Rattenberry E, Bradshaw N, Lalloo F, Izatt L, Cole TR, Armstrong R, Kumar VK, Morrison PJ, Atkinson AB, Douglas F, Ball SG, Cook J, Srirangalingam U, Killick P, Kirby G, Aylwin S, Woodward ER, Evans DG, Hodgson SV, Murday V, Chew SL, Connell JM, Blundell TL, Macdonald F, Maher ER.
    Hum Mutat; 2010 Jan 25; 31(1):41-51. PubMed ID: 19802898
    [Abstract] [Full Text] [Related]

  • 11. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
    Kim JH, Seong MW, Lee KE, Choi HJ, Ku EJ, Bae JH, Park SS, Choi SH, Kim SW, Shin C, Kim SY.
    Clin Genet; 2014 Nov 25; 86(5):482-6. PubMed ID: 24134185
    [Abstract] [Full Text] [Related]

  • 12. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
    Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, Croxson M, Dahia PL, Elston M, Gimm O, Henley D, Herman P, Murday V, Niccoli-Sire P, Pasieka JL, Rohmer V, Tucker K, Jeunemaitre X, Marsh DJ, Plouin PF, Robinson BG.
    J Clin Endocrinol Metab; 2006 Mar 25; 91(3):827-36. PubMed ID: 16317055
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY.
    Turkova H, Prodanov T, Maly M, Martucci V, Adams K, Widimsky J, Chen CC, Ling A, Kebebew E, Stratakis CA, Fojo T, Pacak K.
    Endocr Pract; 2016 Mar 25; 22(3):302-14. PubMed ID: 26523625
    [Abstract] [Full Text] [Related]

  • 15. Genetic testing in pheochromocytoma or functional paraganglioma.
    Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A, Niccoli-Sire P, Richard S, Rohmer V, Sadoul JL, Strompf L, Schlumberger M, Bertagna X, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP.
    J Clin Oncol; 2005 Dec 01; 23(34):8812-8. PubMed ID: 16314641
    [Abstract] [Full Text] [Related]

  • 16. Clinical Aspects of SDHA-Related Pheochromocytoma and Paraganglioma: A Nationwide Study.
    van der Tuin K, Mensenkamp AR, Tops CMJ, Corssmit EPM, Dinjens WN, van de Horst-Schrivers ANA, Jansen JC, de Jong MM, Kunst HPM, Kusters B, Leter EM, Morreau H, van Nesselrooij BMP, Oldenburg RA, Spruijt L, Hes FJ, Timmers HJLM.
    J Clin Endocrinol Metab; 2018 Feb 01; 103(2):438-445. PubMed ID: 29177515
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of germline mutations in patients with pheochromocytoma or abdominal paraganglioma and sporadic presentation: a population-based study in Western Sweden.
    Muth A, Abel F, Jansson S, Nilsson O, Ahlman H, Wängberg B.
    World J Surg; 2012 Jun 01; 36(6):1389-94. PubMed ID: 22270996
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation.
    Kamai T, Murakami S, Arai K, Nishihara D, Uematsu T, Ishida K, Kijima T.
    BMC Cancer; 2022 Mar 18; 22(1):289. PubMed ID: 35300626
    [Abstract] [Full Text] [Related]

  • 19. Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations.
    King KS, Prodanov T, Kantorovich V, Fojo T, Hewitt JK, Zacharin M, Wesley R, Lodish M, Raygada M, Gimenez-Roqueplo AP, McCormack S, Eisenhofer G, Milosevic D, Kebebew E, Stratakis CA, Pacak K.
    J Clin Oncol; 2011 Nov 01; 29(31):4137-42. PubMed ID: 21969497
    [Abstract] [Full Text] [Related]

  • 20. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
    Bayley JP, van Minderhout I, Weiss MM, Jansen JC, Oomen PH, Menko FH, Pasini B, Ferrando B, Wong N, Alpert LC, Williams R, Blair E, Devilee P, Taschner PE.
    BMC Med Genet; 2006 Jan 11; 7():1. PubMed ID: 16405730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.